|
OR |
95%CI |
P value |
OR |
95%CI |
P value
|
Pharmacist-driven ASP group and infectious diseases consultation in
chemotherapy-induced febrile neutropenic patient
|
0.184
|
0.037 – 0.911
|
0.038
|
0.082
|
0.009 – 0.762
|
0.028
|
Male
|
0.653
|
0.176 – 2.419
|
0.524
|
0.836
|
0.164 – 4.266
|
0.830
|
High risk of febrile neutropenia
|
5.426
|
1.098 – 26.829
|
0.038
|
6.513
|
1.036 – 40.941
|
0.046
|
Had history of febrile neutropenia
|
5.143
|
1.040 – 25.420
|
0.045
|
8.034
|
1.321 – 48.848
|
0.024
|
Carbapenem resistance organisms
|
8.111
|
1.015 – 64.839
|
0.048
|
9.985
|
0.418 – 238.455
|
0.155
|